T he CRISPR (clustered regularlyinterspaced short palindromic repeats)/Cas (CRISPR-associated) system of bacteria and archaea constitutes a mechanism of acquired adaptive immunity against phages, which is based on genome-encoded markers of previously infecting phage sequences ("spacers"). As a repository of phage sequences, these spacers make the system particularly suitable for elucidating phage-bacteria interactions in metagenomic studies. Recent metagenomic analyses of CRISPRs associated with the human microbiome intriguingly revealed conserved "memory spacers" shared by bacteria in multiple unrelated, geographically separated individuals. Here, we discuss possible avenues for explaining this phenomenon by integrating insights from CRISPR biology and phage-bacteria ecology, with a special focus on the human gut. We further explore the growing body of evidence for the role of CRISPR/Cas in regulating the interplay between bacteria and lysogenic phages, which may be intimately related to the presence of memory spacers and sheds new light on the multifaceted biological and ecological modes of action of CRISPR/Cas.
IntroductionBacteriophages are known to play a crucial role in shaping the structure, diversity and evolution of microbial communities in various ecological niches. [1][2][3][4] The CRISPR (clustered regularly interspaced short palindromic repeats)/Cas
Holding a grudgePersisting anti-phage CRISPR immunity in multiple human gut microbiomes (CRISPR-associated) system of bacteria and archaea constitutes a mechanism of acquired adaptive immunity against phages, which is based on genomeencoded markers of past infections. 5 The unique biology of this system has opened a window into the multifaceted interactions that take place in natural environments between microbial populations and their associated phages. At the same time, observation of these interactions raises intriguing questions about the underlying mechanistic activity of CRISPR/Cas. Here, we explore this reciprocity with a focus on the microbial community resident in the human gut.CRISPR loci are composed of a succession of short repeat sequences separated by unique "spacer" sequences, usually sized 24-50 bp. While the mechanism of action of the CRISPR/Cas system is not yet fully characterized and some specifics vary by subtype, it generally entails three processes: incorporation of fragments of phage or plasmid genomes as novel spacers in bacterial CRISPR arrays; transcription and processing of the array into small RNAs (crRNAs) and formation of a crRNA/Cas protein complex that recognizes foreign nucleic acids through sequence complementarity and interferes with phage replication. [6][7][8][9][10][11] Elucidation of the function of the CRISPR/Cas system has led to theoretical and experimental efforts at exploring the ecological impacts of CRISPR-mediated immunity, as well as the conditions under which its emergence would be favored. [12][13][14] However, this system provided an ©2012 Landes Bioscience. Do not distribute.